uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
Show others and affiliations
2015 (English)In: Cell reports, ISSN 2211-1247, E-ISSN 2211-1247, Vol. 11, no 7, 1134-1146 p.Article in journal (Refereed) Published
Abstract [en]

Several proteins have been linked to neurodegenerative disorders (NDDs), but their molecular function is not completely understood. Here, we used quantitative interaction proteomics to identify binding partners of Amyloid beta precursor protein (APP) and Presenilin-1 (PSEN1) for Alzheimer's disease (AD), Huntingtin (HTT) for Huntington's disease, Parkin (PARK2) for Parkinson's disease, and Ataxin-1 (ATXN1) for spinocerebellar ataxia type 1. Our network reveals common signatures of protein degradation and misfolding and recapitulates known biology. Toxicity modifier screens and comparison to genome-wide association studies show that interaction partners are significantly linked to disease phenotypes in vivo. Direct comparison of wild-type proteins and disease-associated variants identified binders involved in pathogenesis, highlighting the value of differential interactome mapping. Finally, we show that the mitochondrial protein LRPPRC interacts preferentially with an early-onset AD variant of APP. This interaction appears to induce mitochondrial dysfunction, which is an early phenotype of AD.

Place, publisher, year, edition, pages
2015. Vol. 11, no 7, 1134-1146 p.
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:uu:diva-256232DOI: 10.1016/j.celrep.2015.04.030ISI: 000354719900014PubMedID: 25959826OAI: oai:DiVA.org:uu-256232DiVA: diva2:826134
Available from: 2015-06-24 Created: 2015-06-22 Last updated: 2017-12-04Bibliographically approved

Open Access in DiVA

fulltext(35511 kB)206 downloads
File information
File name FULLTEXT01.pdfFile size 35511 kBChecksum SHA-512
2f726483bbe92d2585d41b0f6f69d1252ae1138f0510bb79b16c2078325a23ca132cb421c5a2d43b6951ce349e0108d4ab29414f74ac02b10c3785aca23d8e73
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Lannfelt, LarsIngelsson, Martin

Search in DiVA

By author/editor
Lannfelt, LarsIngelsson, Martin
By organisation
Geriatrics
In the same journal
Cell reports
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
Total: 206 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 666 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf